FDA truned down Iluvien for the treatment of Diabetic Macular Edema (DME)

被引：0
|
作者：
Idris, Iskandar
机构：
来源：
DIABETES OBESITY & METABOLISM | 2011年 / 13卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 286
页数：2
相关论文
共 50 条
  • [31] Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)
    Jean-Francois Korobelnik
    Jos Kleijnen
    Shona H Lang
    Richard Birnie
    Regina M Leadley
    Kate Misso
    Gill Worthy
    Dominic Muston
    Diana V Do
    BMC Ophthalmology, 15
  • [32] Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
    Sonja G. Karst
    Jan Lammer
    Christoph Mitsch
    Manuela Schober
    Janhvi Mehta
    Christoph Scholda
    Michael Kundi
    Katharina Kriechbaum
    Ursula Schmidt-Erfurth
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 49 - 58
  • [33] Systematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)
    Korobelnik, Jean-Francois
    Kleijnen, Jos
    Lang, Shona H.
    Birnie, Richard
    Leadley, Regina M.
    Misso, Kate
    Worthy, Gill
    Muston, Dominic
    Do, Diana V.
    BMC OPHTHALMOLOGY, 2015, 15
  • [34] ILUVIEN® in diabetic macular edema that persists or recurs despite treatment: Results from the Retina.pt® RIVER audit
    Teixeira, Carla
    Pessoa, Bernardete
    Ruao, Miguel
    Sousa, Joao Paulo Castro
    Penas, Susana
    Silva, Rufino
    Carneiro, Angela
    Meireles, Angelina
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (04) : 1149 - 1158
  • [35] Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
    Karst, Sonja G.
    Lammer, Jan
    Mitsch, Christoph
    Schober, Manuela
    Mehta, Janhvi
    Scholda, Christoph
    Kundi, Michael
    Kriechbaum, Katharina
    Schmidt-Erfurth, Ursula
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (01) : 49 - 58
  • [36] Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
    Dan Călugăru
    Mihai Călugăru
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 1035 - 1037
  • [37] Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
    Calugaru, Dan
    Calugaru, Mihai
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (05) : 1035 - 1037
  • [38] Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in diabetic macular edema (DME).
    Shah, Parth Arvind
    Tang, Yannan
    Rafijah, Neala
    Haskova, Zdenka
    Willis, Jeffrey Ryuta
    Kotecha, Aachal
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [39] Efficacy and safety of corticosteroid implant (Fluocinolone Acetonide (FAc) 0.2 lg/day, Iluvien ®) for management of Diabetic Macular Edema (DME): a real-life study
    Vieira, M.
    Pereira, J.
    Santos, M.
    Arruda, H.
    Sousa, J.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 135 - 136
  • [40] Diabetic Macular Edema: Pathogenesis and Treatment
    Bhagat, Neelakshi
    Grigorian, Ruben A.
    Tutela, Arthur
    Zarbin, Marco A.
    SURVEY OF OPHTHALMOLOGY, 2009, 54 (01) : 1 - 32
12345